Surgical Management of Inferior Turbinate Hypertrophy

Inferior turbinate hypertrophy is a leading cause of chronic nasal obstruction and may persist despite optimal medical therapy. Surgical intervention seeks to reduce turbinate bulk and restore nasal airflow while preserving mucosal function in humidification, filtration and mucociliary clearance. Techniques are broadly categorised into mucosal‐sparing and non‐mucosal‐sparing approaches. Non‐sparing methods, such as partial turbinectomy, achieve substantial volume reduction but carry higher risks of bleeding, crusting and sensory disturbance. Mucosal‐sparing procedures—including submucosal resection, outfracture, radiofrequency ablation, coblation and microdebrider‐assisted turbinoplasty—aim to maintain the epithelial layer and accelerate postoperative recovery. Emerging modalities, notably high‐intensity focused ultrasound, enable targeted tissue ablation with minimal collateral thermal injury. Comparative analyses indicate that mucosal preservation generally results in fewer complications and faster return to function, while some non‐sparing resections may offer greater immediate airway enlargement. Long‐term efficacy and symptom stability vary by technique; current evidence suggests that microdebrider‐assisted turbinoplasty delivers durable relief in many cases. Advances in endoscopic imaging have refined intraoperative assessment, allowing precise tailoring of resection to anatomical and pathological variations. Globally, these surgical innovations have broadened treatment options for patients unresponsive to decongestant and steroid therapy, improving quality of life and reducing reliance on chronic medication.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Surgical Management of Inferior Turbinate Hypertrophy publication trend

The graph below shows the total number of articles in surgical management of inferior turbinate hypertrophy across all publications each year (not limited to Nature Index journals).

Technical terms

Inferior turbinate hypertrophy: pathological enlargement of the lower nasal concha causing airway obstruction.

Turbinoplasty: surgical reshaping or volume reduction of the turbinate bone and soft tissue to improve nasal airflow.

Submucosal resection: removal of stromal tissue beneath the mucosal surface, preserving the overlying epithelium.

Coblation: ablation using radiofrequency energy in a conductive saline field, minimising thermal damage.

High‐intensity focused ultrasound: non-invasive technique delivering focused ultrasonic waves to reduce tissue volume precisely.

Microdebrider: powered, rotating cutting instrument used endoscopically for controlled turbinate tissue removal.

References

1. Ultrastructural regenerating features of nasal mucosa following microdebrider-assisted turbinoplasty are related to clinical recovery. Journal of Translational Medicine (2016).
2. Surgical Interventions for Inferior Turbinate Hypertrophy: A Comprehensive Review of Current Techniques and Technologies. International Journal of Environmental Research and Public Health (2021).
3. The Effectiveness of High-Intensity Focused Ultrasound in Treating Nasal Obstruction Caused by Inferior Turbinate Hypertrophy: A Clinical Study. Cureus (2024).
4. Assessment of the protective role of submucosal saline injection of the inferior turbinates prior to submucosal diathermy or coblation techniques. The Egyptian Journal of Otolaryngology (2023).
5. The submucosal approach influences long-term outcomes of refractory obstructive rhinitis: A prospective study and a STROBE analysis. American Journal of Otolaryngology (2023).